Align Technology, Inc. (0HCK.L)
0HCK.L Stock Price Chart
Explore Align Technology, Inc. interactive price chart. Choose custom timeframes to analyze 0HCK.L price movements and trends.
0HCK.L Company Profile
Discover essential business fundamentals and corporate details for Align Technology, Inc. (0HCK.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Jan 2018
Employees
20.95K
Website
https://www.aligntech.comCEO
Joseph M. Hogan
Description
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
0HCK.L Financial Timeline
Browse a chronological timeline of Align Technology, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 29 Oct 2025
Upcoming earnings on 30 Jul 2025
Revenue estimate is $1.06B.
Earnings released on 30 Apr 2025
EPS came in at $2.13 surpassing the estimated $1.99 by +7.04%, while revenue for the quarter reached $979.26M, beating expectations by +0.35%.
Earnings released on 5 Feb 2025
EPS came in at $1.39 falling short of the estimated $2.45 by -43.27%, while revenue for the quarter reached $995.22M, missing expectations by -0.39%.
Earnings released on 24 Oct 2024
EPS came in at $1.55 falling short of the estimated $2.31 by -32.90%, while revenue for the quarter reached $977.87M, missing expectations by -1.23%.
Earnings released on 25 Jul 2024
EPS came in at $1.28 falling short of the estimated $2.34 by -45.30%, while revenue for the quarter reached $1.03B, missing expectations by -0.89%.
Earnings released on 25 Apr 2024
EPS came in at $1.39 falling short of the estimated $1.97 by -29.44%, while revenue for the quarter reached $997.43M, beating expectations by +2.35%.
Earnings released on 1 Feb 2024
EPS came in at $1.64 falling short of the estimated $2.18 by -24.77%, while revenue for the quarter reached $956.73M, beating expectations by +2.47%.
Earnings released on 26 Oct 2023
EPS came in at $1.58 falling short of the estimated $2.26 by -30.09%, while revenue for the quarter reached $960.21M, missing expectations by -3.45%.
Earnings released on 27 Jul 2023
EPS came in at $1.46 falling short of the estimated $2.03 by -28.08%, while revenue for the quarter reached $1.00B, beating expectations by +1.09%.
Earnings released on 27 Apr 2023
EPS came in at $1.14 falling short of the estimated $1.69 by -32.54%, while revenue for the quarter reached $943.15M, beating expectations by +4.42%.
Earnings released on 2 Feb 2023
EPS came in at $0.54 falling short of the estimated $1.53 by -64.84%, while revenue for the quarter reached $901.52M, beating expectations by +1.09%.
Earnings released on 26 Oct 2022
EPS came in at $0.93 falling short of the estimated $2.16 by -56.99%, while revenue for the quarter reached $890.35M, missing expectations by -7.62%.
Earnings released on 27 Jul 2022
EPS came in at $1.44 falling short of the estimated $2.23 by -35.43%, while revenue for the quarter reached $969.55M, missing expectations by -1.53%.
Earnings released on 27 Apr 2022
EPS came in at $1.70 falling short of the estimated $2.30 by -26.09%, while revenue for the quarter reached $973.22M, missing expectations by -2.87%.
Dividend declared on 15 Mar 2022
A dividend of $0.29 per share was announced, adjusted to $0.29.
Earnings released on 2 Feb 2022
EPS came in at $2.40 falling short of the estimated $2.74 by -12.41%, while revenue for the quarter reached $1.03B, beating expectations by +0.76%.
Earnings released on 27 Oct 2021
EPS came in at $2.51, while revenue for the quarter reached $1.01B.
Earnings released on 30 Sept 2021
EPS came in at $2.28, while revenue for the quarter reached $1.02B.
Earnings released on 31 Mar 2021
EPS came in at $2.51, while revenue for the quarter reached $894.77M.
Earnings released on 31 Dec 2020
EPS came in at $2.00, while revenue for the quarter reached $834.52M.
Earnings released on 30 Sept 2020
EPS came in at $1.76, while revenue for the quarter reached $734.14M.
0HCK.L Stock Performance
Access detailed 0HCK.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.